CCCC

C4 Therapeutics, Inc.

• PUBT·4d ago

  C4 Therapeutics joins TD Cowen Oncology Innovation Summit fireside chat

• PUBT·5d ago

  C4 Therapeutics grants new hire stock options for 85,480 shares under Nasdaq rule

• Reuters·5d ago

  C4 THERAPEUTICS ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

• TipRanks·05/15 21:12

  C4 Therapeutics Realigns Finance Leadership After Officer Departure

• PUBT·05/15 20:07

  C4 Therapeutics names CFO Kendra Adams principal accounting officer, effective May 15

• Simply Wall St·05/15 13:03

  C4 Therapeutics, Inc. (NASDAQ:CCCC) Just Reported And Analysts Have Been Lifting Their Price Targets

• Simply Wall St·05/13 22:49

  C4 Therapeutics (CCCC) Q1 Loss Of US$25.1 Million Reinforces Profitability Concerns

• Benzinga·05/13 17:42

  Nasdaq Surges Over 1%; Alibaba Shares Gain After Q4 Results

• Benzinga·05/13 15:31

  Vishay Intertechnology, Eos Energy Enterprises, Tower Semiconductor And Other Big Stocks Moving Higher On Wednesday

• TipRanks·05/13 09:30

  Analysts Offer Insights on Healthcare Companies: C4 Therapeutics (CCCC), McKesson (MCK) and Universal Health (UHS)

• TipRanks·05/13 09:00

  Analysts Offer Insights on Healthcare Companies: Solid Biosciences (SLDB), C4 Therapeutics (CCCC) and Orchestra BioMed Holdings (OBIO)

• TipRanks·05/12 12:40

  C4 Therapeutics reports Q1 EPS (20c), consensus (26c)

• TipRanks·05/12 12:09

  C4 Therapeutics Reports Q1 Results and Clinical Advancements

• PUBT·05/12 11:21

  C4 Therapeutics publishes corporate presentation on targeted protein degradation pipeline, cemsidomide focus

• Seeking Alpha·05/12 11:10

  C4 Therapeutics GAAP EPS of -$0.20 beats by $0.06, revenue of $6.15M beats by $1.73M